A Practical Guide to Staying on Track GLP-1 medications such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are usually taken once per week
This has raised questions about potential conflicts of interest and highlights the importance of independent research
Clearly the insulin releasing property of GLP-1 is common in tetrapods but its function in venom is novel and monotreme specific
While the relevance of these findings to humans is unclear, caution is advised (FDA n.d.), particularly in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2
[DOI] [PMC free article] [PubMed] [Google Scholar] 85.Vieira A.F., Santos J.S., Costa R.R., Cadore E.L., Macedo R.C.O
This review summarizes the most recent studies that reframe our understanding of the physiology of GLP-1 in health and disease